Expanded Access, or Compassionate Use, is the use of an investigational medicine prior to regulatory approval and outside of an active clinical trial.

Sermonix does not currently have an Expanded Access program for any of our investigational drugs nor can the Company accommodate so-called “Right to Try” requests at this time.

While we understand that it is difficult for patients with serious conditions such as cancer to wait for approved treatments, we believe that devoting our available resources to advancing clinical trial programs towards potential FDA approval provides the best path to achieve our shared ultimate goal of providing patients with access to novel therapies.

We encourage you to consult with your physician about options that may be right for you.